866-997-4948(US-Canada Toll Free)

Global Arthritis Drug Market Insights, Forecast to 2025

Published By :

QYResearch

Published Date : Sep 2018

Category :

Pharmaceutical

No. of Pages : 110 Pages

This report studies the global market size of Arthritis Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Arthritis Drug in these regions.
This research report categorizes the global Arthritis Drug market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

Arthritis is condition that causes pain and inflammation in joints. Around 100 different types of arthritis related conditions present globally and it is one of the leading cause of disability worldwide. The most common types of arthritis includes: Psoriatic Arthritis, Rheumatoid Arthritis, Osteoarthritis, are among others.
Growing burden of incidence of osteoarthritis, psoriatic arthritis and rheumatoid arthritis patients are major factors driving the growth of global arthritis drugs market. According to CDC estimation from 2010-2012, about 52.5 million US adults had some form of arthritis conditions among them persons with age 65 or older reported higher prevalence of arthritis conditions than the other ages due to wear and tear on the joints. However, due to lack of proper medication to cure arthritis and higher cost of the medications are hindering the growth of this market over the forecast period.
In 2017, the global Arthritis Drug market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Arthritis Drug market based on company, product type, application and key regions.

The various contributors involved in the value chain of Arthritis Drug include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Arthritis Drug include
Novartis
Eli Lilly
Celltrion
F. Hoffmann-La Roche
Pfizer
Johnson & Johnson
GSK

Market Size Split by Type
Synthetic DMARDs
Biological DMARDs
NSAIDs
Corticosteroids
Analgesics
Market Size Split by Application
Retail Pharmacies
Hospital Pharmacies
Drug Stores
E-Commerce

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Arthritis Drug market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Arthritis Drug market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Arthritis Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Arthritis Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Arthritis Drug submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Arthritis Drug are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Arthritis Drug market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Study Coverage
1.1 Arthritis Drug Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Arthritis Drug Market Size Growth Rate by Type
1.4.2 Synthetic DMARDs
1.4.3 Biological DMARDs
1.4.4 NSAIDs
1.4.5 Corticosteroids
1.4.6 Analgesics
1.5 Market by Application
1.5.1 Global Arthritis Drug Market Size Growth Rate by Application
1.5.2 Retail Pharmacies
1.5.3 Hospital Pharmacies
1.5.4 Drug Stores
1.5.5 E-Commerce
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Arthritis Drug Market Size
2.1.1 Global Arthritis Drug Revenue 2016-2025
2.1.2 Global Arthritis Drug Sales 2016-2025
2.2 Arthritis Drug Growth Rate by Regions
2.2.1 Global Arthritis Drug Sales by Regions
2.2.2 Global Arthritis Drug Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Arthritis Drug Sales by Manufacturers
3.1.1 Arthritis Drug Sales by Manufacturers
3.1.2 Arthritis Drug Sales Market Share by Manufacturers
3.1.3 Global Arthritis Drug Market Concentration Ratio (CR5 and HHI)
3.2 Arthritis Drug Revenue by Manufacturers
3.2.1 Arthritis Drug Revenue by Manufacturers (2016-2018)
3.2.2 Arthritis Drug Revenue Share by Manufacturers (2016-2018)
3.3 Arthritis Drug Price by Manufacturers
3.4 Arthritis Drug Manufacturing Base Distribution, Product Types
3.4.1 Arthritis Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Arthritis Drug Product Category
3.4.3 Date of International Manufacturers Enter into Arthritis Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Arthritis Drug Sales by Type
4.2 Global Arthritis Drug Revenue by Type
4.3 Arthritis Drug Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Arthritis Drug Breakdown Data by Application

6 North America
6.1 North America Arthritis Drug by Countries
6.1.1 North America Arthritis Drug Sales by Countries
6.1.2 North America Arthritis Drug Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Arthritis Drug by Type
6.3 North America Arthritis Drug by Application
6.4 North America Arthritis Drug by Company

7 Europe
7.1 Europe Arthritis Drug by Countries
7.1.1 Europe Arthritis Drug Sales by Countries
7.1.2 Europe Arthritis Drug Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Arthritis Drug by Type
7.3 Europe Arthritis Drug by Application
7.4 Europe Arthritis Drug by Company

8 Asia Pacific
8.1 Asia Pacific Arthritis Drug by Countries
8.1.1 Asia Pacific Arthritis Drug Sales by Countries
8.1.2 Asia Pacific Arthritis Drug Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Arthritis Drug by Type
8.3 Asia Pacific Arthritis Drug by Application
8.4 Asia Pacific Arthritis Drug by Company

9 Central & South America
9.1 Central & South America Arthritis Drug by Countries
9.1.1 Central & South America Arthritis Drug Sales by Countries
9.1.2 Central & South America Arthritis Drug Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Arthritis Drug by Type
9.3 Central & South America Arthritis Drug by Application
9.4 Central & South America Arthritis Drug by Company

10 Middle East and Africa
10.1 Middle East and Africa Arthritis Drug by Countries
10.1.1 Middle East and Africa Arthritis Drug Sales by Countries
10.1.2 Middle East and Africa Arthritis Drug Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Arthritis Drug by Type
10.3 Middle East and Africa Arthritis Drug by Application
10.4 Middle East and Africa Arthritis Drug by Company

11 Company Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Arthritis Drug
11.1.4 Arthritis Drug Product Description
11.1.5 Recent Development
11.2 Eli Lilly
11.2.1 Eli Lilly Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Arthritis Drug
11.2.4 Arthritis Drug Product Description
11.2.5 Recent Development
11.3 Celltrion
11.3.1 Celltrion Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Arthritis Drug
11.3.4 Arthritis Drug Product Description
11.3.5 Recent Development
11.4 F. Hoffmann-La Roche
11.4.1 F. Hoffmann-La Roche Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Arthritis Drug
11.4.4 Arthritis Drug Product Description
11.4.5 Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Arthritis Drug
11.5.4 Arthritis Drug Product Description
11.5.5 Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Arthritis Drug
11.6.4 Arthritis Drug Product Description
11.6.5 Recent Development
11.7 GSK
11.7.1 GSK Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Arthritis Drug
11.7.4 Arthritis Drug Product Description
11.7.5 Recent Development

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Arthritis Drug Raw Material
13.1.2 Arthritis Drug Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Table

List of Tables and Figures

Figure Picture of Arthritis Drug
Figure Global Arthritis Drug Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Arthritis Drug Production Market Share by Types (Product Category) in 2017
Figure Synthetic DMARDs Product Picture
Table Major Manufacturers of Synthetic DMARDs
Figure Biological DMARDs Product Picture
Table Major Manufacturers of Biological DMARDs
Figure NSAIDs Product Picture
Table Major Manufacturers of NSAIDs
Figure Corticosteroids Product Picture
Table Major Manufacturers of Corticosteroids
Figure Analgesics Product Picture
Table Major Manufacturers of Analgesics
Table Global Arthritis Drug Market Size Growth Rate by Application 2018-2025 (K Units)
Figure Retail Pharmacies
Figure Hospital Pharmacies
Figure Drug Stores
Figure E-Commerce
Figure Arthritis Drug Report Years Considered
Figure Global Arthritis Drug Market Size 2016-2025 (Million US$)
Figure Global Arthritis Drug Sales 2016-2025 (K Units)
Table Global Arthritis Drug Market Size by Regions 2016-2025 (K Units) & (Million US$)
Table Global Arthritis Drug Sales by Regions 2016-2025 (K Units)
Table Global Arthritis Drug Sales Market Share by Regions 2016-2025
Figure Global Arthritis Drug Sales Market Share by Regions 2016-2025
Figure 2017 Global Arthritis Drug Sales Market Share by Regions
Table Global Arthritis Drug Revenue by Regions 2016-2025 (Million US$)
Table Global Arthritis Drug Revenue Market Share by Regions 2016-2025
Figure Global Arthritis Drug Revenue Market Share by Regions 2016-2025
Figure 2017 Global Arthritis Drug Revenue Market Share by Regions
Table Global Arthritis Drug Sales by Manufacturers (2016-2018) (K Units)
Table Global Arthritis Drug Sales Share by Manufacturers (2016-2018)
Figure Global Arthritis Drug Sales Share by Manufacturers in 2017
Table Arthritis Drug Revenue by Manufacturers (2016-2018) (Million US$)
Table Arthritis Drug Revenue Share by Manufacturers (2016-2018)
Figure Arthritis Drug Value Share by Manufacturers in 2017
Table Global Arthritis Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Arthritis Drug Price (2016-2018) (USD/Unit)
Table Arthritis Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Arthritis Drug Product Category
Table Date of International Manufacturers Enter into Arthritis Drug Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Arthritis Drug Sales by Type (2016-2025) (K Units)
Table Global Arthritis Drug Sales Share by Type (2016-2025)
Figure Global Arthritis Drug Sales Market Share by Type (2016-2025)
Figure Global Arthritis Drug Sales Market Share by Type in 2017
Table Global Arthritis Drug Revenue by Type (2016-2025) (Million US$)
Table Global Arthritis Drug Revenue Share by Type (2016-2025)
Figure Global Arthritis Drug Revenue Market Share by Type (2016-2025)
Figure Global Arthritis Drug Revenue Market Share by Type in 2017
Table Arthritis Drug Price by Type 2013-2018 (USD/Unit)
Table Global Arthritis Drug Sales by Application (2016-2025) (K Units)
Table Global Arthritis Drug Sales Share by Application (2016-2025)
Figure Global Sales Arthritis Drug Market Share by Application (2016-2025)
Figure Global Sales Arthritis Drug Market Share by Application (2016-2025)
Figure North America Arthritis Drug Sales Growth Rate 2016-2025 (K Units)
Figure North America Arthritis Drug Revenue Growth Rate 2016-2025 (Million US$)
Table North America Arthritis Drug Sales by Countries (2016-2025) (K Units)
Table North America Arthritis Drug Sales Market Share by Countries (2016-2025)
Figure 2017 North America Arthritis Drug Sales Market Share by Countries
Table North America Arthritis Drug Revenue by Countries (2016-2025) (Million US$)
Table North America Arthritis Drug Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Arthritis Drug Revenue Market Share by Countries
Figure United States Arthritis Drug Sales Growth Rate (2016-2025) (K Units)
Figure United States Arthritis Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Arthritis Drug Sales Growth Rate (2016-2025) (K Units)
Figure Canada Arthritis Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Arthritis Drug Sales Growth Rate (2016-2025) (K Units)
Figure Mexico Arthritis Drug Revenue Growth Rate (2016-2025) (Million US$)
Table North America Arthritis Drug Sales by Type (2016-2025) (K Units)
Table North America Arthritis Drug Sales Market Share by Type (2016-2025)
Figure 2017 North America Arthritis Drug Market Share by Type
Table North America Arthritis Drug Sales by Application (2016-2025) (K Units)
Table North America Arthritis Drug Sales Market Share by Application (2016-2025)
Figure 2017 North America Arthritis Drug Market Share by Application
Table North America Arthritis Drug Sales by Company (2016-2018) (K Units)
Table North America Arthritis Drug Sales Market Share by Company (2016-2018)
Figure North America Arthritis Drug Sales Market Share by Company in 2017
Figure Europe Arthritis Drug Sales Growth Rate 2016-2025 (K Units)
Figure Europe Arthritis Drug Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Arthritis Drug Sales by Countries (2016-2025) (K Units)
Table Europe Arthritis Drug Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Arthritis Drug Sales Market Share by Countries
Table Europe Arthritis Drug Revenue by Countries (2016-2025) (Million US$)
Table Europe Arthritis Drug Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Arthritis Drug Revenue Market Share by Countries
Figure Germany Arthritis Drug Sales Growth Rate (2016-2025) (K Units)
Figure Germany Arthritis Drug Revenue Growth Rate (2016-2025) (K Units)
Figure France Arthritis Drug Sales Growth Rate (2016-2025) (K Units)
Figure France Arthritis Drug Revenue Growth Rate (2016-2025) (K Units)
Figure UK Arthritis Drug Sales Growth Rate (2016-2025) (K Units)
Figure UK Arthritis Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Arthritis Drug Sales Growth Rate (2016-2025) (K Units)
Figure Italy Arthritis Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Arthritis Drug Sales Growth Rate (2016-2025) (K Units)
Figure Russia Arthritis Drug Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Arthritis Drug Sales by Type (2016-2025) (K Units)
Table Europe Arthritis Drug Sales Market Share by Type (2016-2025)
Figure 2017 Europe Arthritis Drug Market Share by Type
Table Europe Arthritis Drug Sales by Application (2016-2025) (K Units)
Table Europe Arthritis Drug Sales Market Share by Application (2016-2025)
Figure 2017 Europe Arthritis Drug Market Share by Application
Table Europe Arthritis Drug Sales by Company (2016-2018) (K Units)
Table Europe Arthritis Drug Sales Market Share by Company (2016-2018)
Figure Europe Arthritis Drug Sales Market Share by Company in 2017
Figure Asia Pacific Arthritis Drug Sales Growth Rate 2016-2025 (K Units)
Figure Asia Pacific Arthritis Drug Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Arthritis Drug Sales by Countries (2016-2025) (K Units)
Table Asia Pacific Arthritis Drug Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Arthritis Drug Sales Market Share by Countries
Table Asia Pacific Arthritis Drug Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Arthritis Drug Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Arthritis Drug Revenue Market Share by Countries
Figure China Arthritis Drug Sales Growth Rate (2016-2025) (K Units)
Figure China Arthritis Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Arthritis Drug Sales Growth Rate (2016-2025) (K Units)
Figure Japan Arthritis Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Arthritis Drug Sales Growth Rate (2016-2025) (K Units)
Figure Korea Arthritis Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure India Arthritis Drug Sales Growth Rate (2016-2025) (K Units)
Figure India Arthritis Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Arthritis Drug Sales Growth Rate (2016-2025) (K Units)
Figure Australia Arthritis Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Arthritis Drug Sales Growth Rate (2016-2025) (K Units)
Figure Indonesia Arthritis Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Arthritis Drug Sales Growth Rate (2016-2025) (K Units)
Figure Malaysia Arthritis Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Arthritis Drug Sales Growth Rate (2016-2025) (K Units)
Figure Philippines Arthritis Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Arthritis Drug Sales Growth Rate (2016-2025) (K Units)
Figure Thailand Arthritis Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Arthritis Drug Sales Growth Rate (2016-2025) (K Units)
Figure Vietnam Arthritis Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Arthritis Drug Sales Growth Rate (2016-2025) (K Units)
Figure Singapore Arthritis Drug Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Arthritis Drug Sales by Type (2016-2025) (K Units)
Table Asia Pacific Arthritis Drug Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Arthritis Drug Market Share by Type
Table Asia Pacific Arthritis Drug Sales by Application (2016-2025) (K Units)
Table Asia Pacific Arthritis Drug Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Arthritis Drug Market Share by Application
Table Asia Pacific Arthritis Drug Sales by Company (2016-2018) (K Units)
Table Asia Pacific Arthritis Drug Sales Market Share by Company (2016-2018)
Figure Asia Pacific Arthritis Drug Sales Market Share by Company in 2017
Figure Central & South America Arthritis Drug Sales Growth Rate 2016-2025 (K Units)
Figure Central & South America Arthritis Drug Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Arthritis Drug Sales by Countries (2016-2025) (K Units)
Table Central & South America Arthritis Drug Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Arthritis Drug Sales Market Share by Countries
Table Central & South America Arthritis Drug Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Arthritis Drug Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Arthritis Drug Revenue Market Share by Countries
Figure Brazil Arthritis Drug Sales Growth Rate (2016-2025) (K Units)
Figure Brazil Arthritis Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Arthritis Drug Sales Growth Rate (2016-2025) (K Units)
Figure Argentina Arthritis Drug Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Arthritis Drug Sales by Type (2016-2025) (K Units)
Table Central & South America Arthritis Drug Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Arthritis Drug Market Share by Type
Table Central & South America Arthritis Drug Sales by Application (2016-2025) (K Units)
Table Central & South America Arthritis Drug Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Arthritis Drug Market Share by Application
Table Central & South America Arthritis Drug Sales by Company (2016-2018) (K Units)
Table Central & South America Arthritis Drug Sales Market Share by Company (2016-2018)
Figure Central & South America Arthritis Drug Sales Market Share by Company in 2017
Figure Middle East and Africa Arthritis Drug Sales Growth Rate 2016-2025 (K Units)
Figure Middle East and Africa Arthritis Drug Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Arthritis Drug Sales by Countries (2016-2025) (K Units)
Table Middle East and Africa Arthritis Drug Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Arthritis Drug Sales Market Share by Countries
Table Middle East and Africa Arthritis Drug Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Arthritis Drug Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Arthritis Drug Revenue Market Share by Countries
Figure GCC Countries Arthritis Drug Sales Growth Rate (2016-2025) (K Units)
Figure GCC Countries Arthritis Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Arthritis Drug Sales Growth Rate (2016-2025) (K Units)
Figure Turkey Arthritis Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Arthritis Drug Sales Growth Rate (2016-2025) (K Units)
Figure Egypt Arthritis Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Arthritis Drug Sales Growth Rate (2016-2025) (K Units)
Figure South Africa Arthritis Drug Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Arthritis Drug Sales by Type (2016-2025) (K Units)
Table Middle East and Africa Arthritis Drug Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Arthritis Drug Market Share by Type
Table Middle East and Africa Arthritis Drug Sales by Application (2016-2025) (K Units)
Table Middle East and Africa Arthritis Drug Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Arthritis Drug Market Share by Application
Table Middle East and Africa Arthritis Drug Sales by Company (2016-2018) (K Units)
Table Middle East and Africa Arthritis Drug Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Arthritis Drug Sales Market Share by Company in 2017
Table Novartis Company Details
Table Novartis Arthritis Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Novartis Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Arthritis Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Eli Lilly Recent Development
Table Celltrion Company Details
Table Celltrion Arthritis Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Celltrion Recent Development
Table F. Hoffmann-La Roche Company Details
Table F. Hoffmann-La Roche Arthritis Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table F. Hoffmann-La Roche Recent Development
Table Pfizer Company Details
Table Pfizer Arthritis Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Pfizer Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Arthritis Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Johnson & Johnson Recent Development
Table GSK Company Details
Table GSK Arthritis Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table GSK Recent Development
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Arthritis Drug Value Chain
Table Typical Suppliers of Key Arthritis Drug Raw Material
Table Arthritis Drug Customers List
Table Arthritis Drug Sales Channels
Table Arthritis Drug Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *